CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
zanubrutinib Sensitive: C3 – Early Trials
|
zanubrutinib Sensitive: C3 – Early Trials
|
CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
CD79A mutation
|
Diffuse Large B Cell Lymphoma
|
rituximab + zanubrutinib Sensitive: C3 – Early Trials
|
rituximab + zanubrutinib Sensitive: C3 – Early Trials
|